Adele Gautier: Breast Cancer Foundation researcher discusses Pharmac consideration of switch to Herzuma
Early Edition with Ryan Bridge · Newstalk ZB
June 8, 20234m 12s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Changes are on the cards for some breast cancer patients.
Pharmac is consulting on a drug switch proposal to replace the current expired one.
Herzuma is said to be more safe and cost effective, but at what there are concerns about whether all patients will be suited to it.
Breast Cancer Foundation's Research and Strategics Manager, Adele Gautier, joined Kate Hawkesby.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
Topics
Health